observed an independent prognostic feature of OX40 when they assessed the effect of PD-L1 co-expression, suggesting that OX40 is a stronger driver of survival than PD-L1 in non-small-cell lung cancer (30). This evidence concerns the gene CD274 and non-small cell lung carcinoma.